292 related articles for article (PubMed ID: 21282378)
1. The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.
Takashima S; Kadowaki M; Aoyama K; Koyama M; Oshima T; Tomizuka K; Akashi K; Teshima T
J Exp Med; 2011 Feb; 208(2):285-94. PubMed ID: 21282378
[TBL] [Abstract][Full Text] [Related]
2. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.
Ara T; Hashimoto D
Front Immunol; 2021; 12():713631. PubMed ID: 34512636
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.
Hanash AM; Dudakov JA; Hua G; O'Connor MH; Young LF; Singer NV; West ML; Jenq RR; Holland AM; Kappel LW; Ghosh A; Tsai JJ; Rao UK; Yim NL; Smith OM; Velardi E; Hawryluk EB; Murphy GF; Liu C; Fouser LA; Kolesnick R; Blazar BR; van den Brink MR
Immunity; 2012 Aug; 37(2):339-50. PubMed ID: 22921121
[TBL] [Abstract][Full Text] [Related]
4. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease.
Hayase E; Hashimoto D; Nakamura K; Noizat C; Ogasawara R; Takahashi S; Ohigashi H; Yokoi Y; Sugimoto R; Matsuoka S; Ara T; Yokoyama E; Yamakawa T; Ebata K; Kondo T; Hiramine R; Aizawa T; Ogura Y; Hayashi T; Mori H; Kurokawa K; Tomizuka K; Ayabe T; Teshima T
J Exp Med; 2017 Dec; 214(12):3507-3518. PubMed ID: 29066578
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.
Lindemans CA; Calafiore M; Mertelsmann AM; O'Connor MH; Dudakov JA; Jenq RR; Velardi E; Young LF; Smith OM; Lawrence G; Ivanov JA; Fu YY; Takashima S; Hua G; Martin ML; O'Rourke KP; Lo YH; Mokry M; Romera-Hernandez M; Cupedo T; Dow L; Nieuwenhuis EE; Shroyer NF; Liu C; Kolesnick R; van den Brink MRM; Hanash AM
Nature; 2015 Dec; 528(7583):560-564. PubMed ID: 26649819
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
7. [Graft-versus-host disease targets R-spondin3-producing lymphatic endothelial cells in the small intestine].
Ogasawara R
Rinsho Ketsueki; 2020; 61(6):621-627. PubMed ID: 32624535
[TBL] [Abstract][Full Text] [Related]
8. Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration.
Sorrentino G; Perino A; Yildiz E; El Alam G; Bou Sleiman M; Gioiello A; Pellicciari R; Schoonjans K
Gastroenterology; 2020 Sep; 159(3):956-968.e8. PubMed ID: 32485177
[TBL] [Abstract][Full Text] [Related]
9. Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
[TBL] [Abstract][Full Text] [Related]
10. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.
Xing S; Zhang X; Liu JH; Huang X; Zhou P
Clin Exp Immunol; 2019 Jan; 195(1):121-131. PubMed ID: 30317551
[TBL] [Abstract][Full Text] [Related]
11. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.
Zhao D; Kim YH; Jeong S; Greenson JK; Chaudhry MS; Hoepting M; Anderson ER; van den Brink MR; Peled JU; Gomes AL; Slingerland AE; Donovan MJ; Harris AC; Levine JE; Ozbek U; Hooper LV; Stappenbeck TS; Ver Heul A; Liu TC; Reddy P; Ferrara JL
J Clin Invest; 2018 Nov; 128(11):4970-4979. PubMed ID: 30106382
[TBL] [Abstract][Full Text] [Related]
12. IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease.
Henden AS; Koyama M; Robb RJ; Forero A; Kuns RD; Chang K; Ensbey KS; Varelias A; Kazakoff SH; Waddell N; Clouston AD; Giri R; Begun J; Blazar BR; Degli-Esposti MA; Kotenko SV; Lane SW; Bowerman KL; Savan R; Hugenholtz P; Gartlan KH; Hill GR
Blood; 2021 Aug; 138(8):722-737. PubMed ID: 34436524
[TBL] [Abstract][Full Text] [Related]
13. R-Spondin1 protects gastric stem cells and mitigates gastric GVHD in allogeneic hematopoietic stem cell transplantation.
Hayase E; Ara T; Saito Y; Takahashi S; Yoshioka K; Ohigashi H; Ogasawara R; Yokoyama E; Yamakawa T; Ebata K; Hasegawa Y; Tomizuka K; Teshima T
Blood Adv; 2024 Feb; 8(3):725-731. PubMed ID: 38147622
[TBL] [Abstract][Full Text] [Related]
14. T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation.
Fu YY; Egorova A; Sobieski C; Kuttiyara J; Calafiore M; Takashima S; Clevers H; Hanash AM
Immunity; 2019 Jul; 51(1):90-103.e3. PubMed ID: 31278057
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease.
Krijanovski OI; Hill GR; Cooke KR; Teshima T; Crawford JM; Brinson YS; Ferrara JL
Blood; 1999 Jul; 94(2):825-31. PubMed ID: 10397751
[TBL] [Abstract][Full Text] [Related]
16. Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease.
Takahashi S; Hashimoto D; Hayase E; Ogasawara R; Ohigashi H; Ara T; Yokoyama E; Ebata K; Matsuoka S; Hill GR; Sugita J; Onozawa M; Teshima T
Blood; 2018 May; 131(18):2074-2085. PubMed ID: 29363542
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?
Holler E; Ertl B; Hintermeier-Knabe R; Roncarolo MG; Eissner G; Mayer F; Fraunberger P; Behrends U; Pfannes W; Kolb HJ; Wilmanns W
Leuk Lymphoma; 1997 Apr; 25(3-4):217-24. PubMed ID: 9168432
[TBL] [Abstract][Full Text] [Related]
18. Denuded bowel after recovery from graft-versus-host disease.
Fox RJ; Vogelsang GB; Beschorner WE
Transplantation; 1996 Dec; 62(11):1681-4. PubMed ID: 8970630
[TBL] [Abstract][Full Text] [Related]
19. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
20. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
